From: Association between age and the host response in critically ill patients with sepsis
 |  < 50 years |  ≥ 50–< 60 years |  ≥ 60–< 70 years |  ≥ 70 years | p value |
---|---|---|---|---|---|
n | 421 | 368 | 545 | 618 | Â |
Demographics | |||||
Age years, median [IQR] | 39.00 [30.00, 45.00]*ab | 55.00 [53.00, 57.00]*a | 65.00 [62.00, 67.00]* | 76.00 [72.00, 80.00] |  < 0.001 |
Male sex, n (%) | 234 (55.6)*b | 251 (68.2) | 339 (62.2) | 394 (63.8) | 0.003 |
White race, n (%) | 336 (80.0)*ab | 331 (89.9)* | 499 (92.1) | 584 (95.0) |  < 0.001 |
BMI, median [IQR] | 23.71 [21.51, 27.16]*ab | 24.69 [21.61, 28.05]*a | 25.71 [22.84, 29.39] | 25.42 [22.86, 28.40] |  < 0.001 |
Medical admission, n (%) | 307 (72.9) | 277 (75.3) | 408 (74.9) | 452 (73.1) | 0.799 |
Comorbidity | |||||
Charlson scorec, median [IQR] | 0.00 [0.00, 2.00]*ab | 1.00 [0.00, 3.00] *a | 2.00 [0.00, 3.00] | 2.00 [1.00, 3.00] |  < 0.001 |
Cardiovascular, n (%) | 46 (10.9)*ab | 76 (20.7)*a | 163 (29.9)* | 227 (36.7) |  < 0.001 |
Respiratory insufficiency, n (%) | 24 (5.7)*a | 22 (6.0) *a | 52 (9.5) | 59 (9.5) | 0.032 |
Hypertension, n (%) | 57 (13.5)*ab | 85 (23.1) *a | 193 (35.4)* | 268 (43.4) |  < 0.001 |
Diabetes, n (%) | 43 (10.2)*a | 56 (15.2)*a | 128 (23.5) | 160 (25.9) |  < 0.001 |
Malignancy, n (%) | 71 (16.9)*ab | 97 (26.4) | 155 (28.4) | 148 (23.9) |  < 0.001 |
Renal disease, n (%) | 38 (9.0)*ab | 55 (14.9) | 83 (15.2) | 89 (14.4) | 0.022 |
Immunocompromised, n (%) | 114 (27.1)* | 92 (25.1)* | 136 (25.0)* | 96 (15.6) |  < 0.001 |
Chronic medication, n (%) | |||||
Anticoagulants | 34 (8.1)*a | 38 (10.4)*a | 98 (18.0) | 131 (21.2) |  < 0.001 |
Antiplatelet drugs | 23 (5.7)*ab | 62 (17.4)*a | 139 (26.5)* | 254 (42.2) |  < 0.001 |
Site of infection, n (%) | |||||
Cardiovascular | 18 (4.3) | 8 (2.2) | 19 (3.5) | 20 (3.2) | 0.431 |
Pulmonary | 193 (45.8) | 160 (43.5) | 232 (42.6) | 280 (45.3) | 0.700 |
Urinary | 20 (4.8) | 13 (3.5) | 37 (6.8) | 34 (5.5) | 0.174 |
Skin | 19 (4.5) | 17 (4.6) | 14 (2.6) | 23 (3.7) | 0.312 |
Abdominal | 48 (11.4) | 56 (15.2) | 78 (14.3) | 94 (15.2) | 0.314 |
Central nervous system | 32 (7.6)*ab | 13 (3.5) | 19 (3.5) | 10 (1.6) |  < 0.001 |
Other infection sited | 15 (3.6) | 19 (5.2) | 33 (6.1) | 27 (4.4) | 0.304 |
Mixed infection | 70 (16.6) | 79 (21.5) | 103 (18.9) | 114 (18.4) | 0.380 |
Unknown site **b | 15 (3.6) | 14 (3.8) | 21 (3.9) | 31 (5.0) | 0.623 |
Causative pathogen primary site of infectione, n (%) | |||||
Gram-positive bacteria | 150 (35.8) | 121 (33.2) | 187 (34.4) | 201 (32.8) | 0.764 |
Gram-negative bacteria | 111 (26.5)*a | 117 (32.1) | 189 (34.7) | 209 (34.1) | 0.031 |
Fungi | 31 (7.4) | 35 (9.6) | 53 (9.7)* | 34 (5.5) | 0.032 |
Virus | 28 (6.7)* | 17 (4.7) | 29 (5.3) | 16 (2.6) | 0.017 |
Other | 18 (4.3) | 6 (1.6) | 17 (3.1) | 15 (2.4) | 0.138 |
Unknown | 145 (34.6) | 130 (35.6) | 176 (32.4) | 225 (36.7) | 0.470 |
Disease severity on admission | |||||
APACHE IV APS, median [IQR] | 63.00 [47.00, 81.00] | 67.00 [49.00, 84.25] | 65.00 [50.00, 86.00] | 67.00 [51.00, 85.00] | 0.140 |
SOFA scoref, median [IQR] | 6.00 [3.00, 9.00]*ab | 7.00 [4.00, 9.00] | 7.00 [4.00, 9.00] | 7.00 [5.00, 9.00] | 0.001 |
Shock, n (%) | 71 (16.9)*b | 93 (25.3) | 117 (21.5)* | 175 (28.3) |  < 0.001 |
ARDS, n (%) | 93 (22.1) | 89 (24.2) | 113 (20.7) | 126 (20.4) | 0.514 |
Acute kidney injury, n (%) | 110 (26.1)* | 121 (32.9) | 167 (30.6)* | 237 (38.3) |  < 0.001 |